Hemoconcentration is a valuable predictor of prognosis in patients with acute heart failure

Yan,Qian; Chen,Sanfeng

doi:10.3892/etm.2020.8515

Hemoconcentration is a valuable predictor of prognosis in patients with acute heart failure

Authors:
- Qian Yan
- Sanfeng Chen
View Affiliations

Affiliations: Department of Emergency, Affiliated Hospital of Hangzhou Normal University, Hangzhou, Zhejiang 310015, P.R. China, Department of Internal Medicine, Aged Care Hospital of Zhejiang, Hangzhou, Zhejiang 310015, P.R. China
Published online on: February 11, 2020 https://doi.org/10.3892/etm.2020.8515
Pages: 2792-2798

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study was designed to investigate the value of the hemoconcentration (HCT) in predicting the prognosis of patients with acute heart failure (AHF). A total of 188 patients with AHF were enrolled in the present retrospective study and divided into four groups based on their HCT values. The endpoint was either cardiac‑associated death or re‑hospitalization due to aggravated HF. The 2‑year survival rates of patients in these four groups were compared. The area under the receiver operating characteristic curve (AUC) was determined to evaluate the significance of HCT for assessing the prognosis of patients with AHF. Cox‑proportional hazards regression models were performed to determine whether the HCT is an independent factor for predicting the prognosis of patients with AHF in comparison with other traditional predictors, including B‑type natriuretic peptide (BNP) and creatinine. Of these 188 patients with AHF, 99 experienced aggravated cardiac HF resulting in death or re‑hospitalization within 2 years. The AUC for HCT, as a prognostic criterion, was 0.610 (95% confidence interval: 0.528‑0.691, P<0.001) with a sensitivity of 54.5% and a specificity of 65.2%. Kaplan‑Meier analysis indicated that patients with a higher HCT had a lower rate of death or re‑hospitalization due to cardiogenic events (χ2=9.442, P=0.024). Cox regression analysis revealed that HCT, hemoglobin, BNP, New York Heart Association cardiac function classification and serum creatinine were independent prognostic factors in AHF. HCT may serve as a valuable predictor of prognosis in patients with AHF. Compared with that of BNP, measurement of the HCT is more convenient and economical and may be widely performed at primary hospitals.

View Figures

View References

1	Gheorghiade M, Zannad F, Sopko G, Klein L, Piña IL, Konstam MA, Massie BM, Roland E, Targum S, Collins SP, et al: Acute heart failure syndromes: Current state and framework for future research. Circulation. 112:3958–3968. 2005.PubMed/NCBI View Article : Google Scholar
2	Kurmani S and Squire I: Acute heart failure: Definition, classification and epidemiology. Current Heart Fail Rep. 14:385–392. 2017.PubMed/NCBI View Article : Google Scholar
3	Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, LeWinter MM, Deswal A, Rouleau JL, Ofili EO, et al: Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 364:797–805. 2011.PubMed/NCBI View Article : Google Scholar
4	Fonarow GC: Refining classification of heart failure based on ejection fraction. JACC Heart Fail. 5:808–809. 2017. View Article : Google Scholar
5	Raphael C, Briscoe C, Davies J, Ian Whinnett Z, Manisty C, Sutton R, Mayet J and Francis DP: Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart. 93:476–482. 2007.PubMed/NCBI View Article : Google Scholar
6	Richards AM: Biomarkers in acute heart failure-cardiac and kidney. Card Fail Rev. 1:107–111. 2015.PubMed/NCBI View Article : Google Scholar
7	Ray SG: Natriuretic peptides in heart valve disease. Heart. 92:1194–1197. 2006.PubMed/NCBI View Article : Google Scholar
8	Ardissino G, Daccò V, Testa S, Civitillo CF, Tel F, Possenti I, Belingheri M, Castorina P, Bolsa-Ghiringhelli N, Tedeschi S, et al: Hemoconcentration: A major risk factor for neurological involvement in hemolytic uremic syndrome. Pediatr Nephrol. 30:345–352. 2015.PubMed/NCBI View Article : Google Scholar
9	Davila C, Reyentovich A and Katz SD: Clinical correlates of hemoconcentration during hospitalization for acute decompensated heart failure. J Card Fail. 17:1018–1022. 2011.PubMed/NCBI View Article : Google Scholar
10	Oh J, Kang SM, Kim IC, Han S, Yoo BS, Choi DJ, Kim JJ, Jeon ES, Cho MC, Oh BH, et al: The beneficial prognostic value of hemoconcentration is negatively affected by hyponatremia in acute decompensated heart failure: Data from the Korean Heart Failure (KorHF) Registry. J Cardiol. 69:790–796. 2017.PubMed/NCBI View Article : Google Scholar
11	Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie BM and Shlipak MG: Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: The Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation. 113:2713–2723. 2006.PubMed/NCBI View Article : Google Scholar
12	Mozaffarian D, Nye R and Levy WC: Anemia predicts mortality in severe heart failure: The prospective randomized amlodipine survival evaluation (PRAISE). J Am Coll Cardiol. 41:1933–1939. 2003.PubMed/NCBI View Article : Google Scholar
13	Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, et al: Executive summary: Heart disease and stroke statistics-2010 update: A report from the American Heart Association. Circulation. 121:948–954. 2010.PubMed/NCBI View Article : Google Scholar
14	Testani JM, Brisco MA, Chen J, McCauley BD, Parikh CR and Tang WH: Timing of hemoconcentration during treatment of acute decompensated heart failure and subsequent survival: Importance of sustained decongestion. J Am Coll Cardiol. 62:516–524. 2013.PubMed/NCBI View Article : Google Scholar
15	O'Connell JB and Bristow MR: Economic impact of heart failure in the United States: Time for a different approach. J Heart Lung Transplant. 13(S107-S112)1994.PubMed/NCBI
16	Yancy CW, Lopatin M, Stevenson LW, De Marco T and Fonarow GC: ADHERE Scientific Advisory Committee and Investigators: Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: A report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol. 47:76–84. 2006.PubMed/NCBI View Article : Google Scholar
17	Waldum B, Westheim AS, Sandvik L, Flønæs B, Grundtvig M, Gullestad L, Hole T and Os I: Baseline anemia is not a predictor of all-cause mortality in outpatients with advanced heart failure or severe renal dysfunction. Results from the Norwegian Heart Failure Registry. J Am Coll Cardiol. 59:371–378. 2012.PubMed/NCBI View Article : Google Scholar
18	Alexandrakis MG and Tsirakis G: Anemia in heart failure patients. ISRN Hematol. 2012(246915)2012. View Article : Google Scholar
19	Oh J, Kang SM, Hong N, Youn JC, Han S, Jeon ES, Cho MC, Kim JJ, Yoo BS, Chae SC, et al: Hemoconcentration is a good prognostic predictor for clinical outcomes in acute heart failure: Data from the Korean Heart Failure (KorHF) Registry. Int J Cardiol. 168:4739–4743. 2013.PubMed/NCBI View Article : Google Scholar
20	Ter Maaten JM, Valente MA, Damman K, Cleland JG, Givertz MM, Metra M, O'Connor CM, Teerlink JR, Ponikowski P, Bloomfield DM, et al: Combining diuretic response and hemoconcentration to predict rehospitalization after admission for acute heart failure. Circ Heart Fail. 9:2016.PubMed/NCBI View Article : Google Scholar
21	Cataliotti A, Boerrigter G, Costello-Boerrigter LC, Schirger JA, Tsuruda T, Heublein DM, Chen HH, Malatino LS and Burnett JC Jr: Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure. Circulation. 109:1680–1685. 2004.PubMed/NCBI View Article : Google Scholar
22	Durak-Nalbantić A, Džubur A, Dilić M, Pozderac Z, Mujanović-Narančić A, Kulić M, Hodžić E, Resić N, Brdjanović S and Zvizdić F: Brain natriuretic peptide release in acute myocardial infarction. Bosn J Basic Med Sci. 12:164–168. 2012.PubMed/NCBI View Article : Google Scholar
23	Eindhoven JA, van den Bosch AE, Jansen PR, Boersma E and Roos-Hesselink JW: The usefulness of brain natriuretic peptide in complex congenital heart disease: A systematic review. J Am Coll Cardiol. 60:2140–2149. 2012.PubMed/NCBI View Article : Google Scholar
24	Roberts E, Ludman AJ, Dworzynski K, Al-Mohammad A, Cowie MR, McMurray JJ and Mant J: NICE Guideline Development Group for Acute Heart Failure: The diagnostic accuracy of the natriuretic peptides in heart failure: Systematic review and diagnostic meta-analysis in the acute care setting. BMJ. 350(h910)2015.PubMed/NCBI View Article : Google Scholar
25	Di Angelantonio E, Chowdhury R, Sarwar N, Ray KK, Gobin R, Saleheen D, Thompson A, Gudnason V, Sattar N and Danesh J: B-type natriuretic peptides and cardiovascular risk: Systematic review and meta-analysis of 40 prospective studies. Circulation. 120:2177–2187. 2009.PubMed/NCBI View Article : Google Scholar
26	van Veldhuisen DJ, Linssen GC, Jaarsma T, van Gilst WH, Hoes AW, Tijssen JG, Paulus WJ, Voors AA and Hillege HL: B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction. J Am Coll Cardiol. 61:1498–1506. 2013.PubMed/NCBI View Article : Google Scholar
27	Iacoviello M, Leone M, Antoncecchi V and Ciccone MM: Evaluation of chronic kidney disease in chronic heart failure: From biomarkers to arterial renal resistances. World J Clin Cases. 3:10–19. 2015.PubMed/NCBI View Article : Google Scholar
28	Koglin J, Pehlivanli S, Schwaiblmair M, Vogeser M, Cremer P and vonScheidt W: Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol. 38:1934–1941. 2001.PubMed/NCBI View Article : Google Scholar
29	Shlipak MG, Chertow GC and Massie BM: Beware the rising creatinine level. J Card Fail. 9:26–28. 2003.PubMed/NCBI View Article : Google Scholar
30	Arakawa K, Ando Y, Matsunaga S and Nishiura A: Diagnostic ability of natriuretic peptides for heart failure according to eGFR level: Comparison between brain natriuretic peptide and amino-terminal probrain natriuretic peptide. Rinsho Byori. 64:251–257. 2016.(In Japanese). PubMed/NCBI